Figure 2. Accelerated expansion of maternal Tregs with fetal-specificity during secondary pregnancy.
a, Percent Foxp3+ among virgin (primary pregnancy) or postpartum (secondary pregnancy) females before mating or midgestation (E11.5) by Balb/c-2W1S males. b, Percent Foxp3+ among postpartum donor (CD45.1+) or naïve recipient (CD45.2+) 2W1S+ CD4 cells midgestation by Balb/c-2W1S males. c, Percent Foxp3+ among Treg-ablated Foxp3DTR/DTR postpartum donor (CD45.1+) or naïve recipient (CD45.2+) 2W1S+ CD4 cells midgestation. Bar, mean ± one standard error.
